See also this year's filing and all EDGAR filings for this company.
PDF Report 0001321834_2019_MyMD_Pharmaceuticals_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.12713293199370598, 'aggregate_val': 7807253, 'exp_sum': 8944378, 'exp_to_value': {'AssetsCurrent': 6670128, 'AssetsNoncurrent': 1137125, 'PropertyPlantAndEquipmentNet': 83456, 'Goodwill': 243411, 'remainder_Assets': 810258}} |
Graph
Absolute values for 0001321834, MyMD Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 1,973,500 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 6,670,128 |
| 4 | AssetsNoncurrent | 1,137,125 |
| 5 | PropertyPlantAndEquipmentNet | 83,456 |
| 6 | Goodwill | 243,411 |
| 7 | remainder_Assets | -326,867 |
| 8 | GeneralAndAdministrativeExpense | 8,986,618 |
| 9 | ResearchAndDevelopmentExpense | 1,063,253 |
| 10 | remainder_Expenses | 1,676,108 |
| 11 | remainder_Revenues | 1,665,570 |
| 12 | remainder_NetIncome | 788,625 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 1,973,500 |
| 1 | Assets | 7,807,253 |
| 2 | Expenses | 11,725,979 |
| 3 | Revenues | 1,665,570 |
| 4 | StockholdersEquity | 5,833,753 |
| 5 | NetIncome | -9,271,784 |
| 6 | ComprehensiveNetIncome | -9,271,784 |
| 7 | BaseVar | 11,980,464 |
| 8 | EconomicCapitalRatio | -0.882 |